Feasibility of developing a tailored rehabilitation programme to reduce the respiratory symptoms of Long COVID in rural Tamil Nadu.

Feasibility of a tailored Pulmonary Rehabilitation program to improve functional capability and reduce breathlessness among a cohort of Long COVID patients with respiratory symptoms in rural Tamil Nadu: an implementation trial.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/091027

Enrollment

120

Registered

2025-07-16

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: U071- COVID 19 virus identified

Interventions

Intervention1: Long COVID tailored Pulmonary Rehabilitation (PR) Intervention (Long COVID-T-PR): The Long COVID-T-PR group will receive exercise training and educational session for 8 weeks in RUHSA P

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants from the prevalence study with confirmed respiratory symptoms with or without respiratory structural and functional abnormality. 2. Participants with FEV1/FVC less than 0.7 in post bronchospirometry. 3. Participants with modified Medical Research Council Dyspnoea Scale (mMRC) greater than or equal to 2 4. Participants with checklist Individual Strength (CIS)-fatigue greater than or equal to 36 5. Participants with post-COVID-19 Functional Status (PCFS) greater than or equal to 2.

Exclusion criteria

Exclusion criteria: 1. If they have a known or self-reported cognitive, hearing, visual, neurological or musculoskeletal conditions that preclude participation in PR. 2. Any diagnosis of angina pectoris, recent myocardial infarction, severe pulmonary hypertension, congestive heart failure, unstable diabetes. 3. Inability to do exercise due to orthopaedic or other reasons. 4. Psychiatric illness. 5. Severe exercise-induced hypoxemia, not correctable with O2 supplementation 6. Unwilling to give consent

Design outcomes

Primary

Measure	Time frame
Endurance shuttle walking test (ESWT) to measure exercise capacity.Timepoint: 0 - Baseline 10 - 12 weeks - Endline	—

Secondary

Measure	Time frame
1. St Georges Respiratory Questionnaire (SGRQ) 2. MRC Dyspnoea Scale (mMRC) 3. Hospital Anxiety and Depression Score (HADS) 4. London Chest Activities of Daily Living (LCADL) 5. Internation Physical Activity Questionnaire (IPAQ)Timepoint: 0 - Baseline 10 - 12 weeks - Endline	—

Countries

India

Contacts

Public ContactDr Biswajit Paul

Christian Medical College, Vellore

drbpaul@cmcvellore.ac.in8124034755

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026